EXOME

all the information, none of the junk | biotech • healthcare • life sciences

$15M for Aptus Endosystems

Aptus Endosystems in Sunnyvale, CA, which makes devices for endovascular surgery to repair aortic aneurysms, said in a statement yesterday that it has raised $15 million in “Series AA” funding. U.S. Ventures and Longitude Capital led the round, which brings Aptus’s total venture funding to at least $65 million. The company said it will use the funds to pursue regulatory approval and commercialization of its “EndoStapling” system for aneurysm repair in the U.S. and Europe, and to develop thoracic and abdominal versions of the technology.